These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 2417564)

  • 1. [Combination chemotherapy for bronchogenic carcinoma based on cell type].
    Ohta M; Hara N; Ichikawa Y; Kanda T; Shima K; Hokama M
    Gan To Kagaku Ryoho; 1986 Jan; 13(1):86-94. PubMed ID: 2417564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Benefits of cisplatin-based polychemotherapy in non-small cell bronchogenic carcinoma. Kyushu Lung Cancer Chemotherapy Study Group].
    Ohta M; Hara N; Ichikawa Y; Kanda T; Shima K; Tamura K; Hokama M
    Gan To Kagaku Ryoho; 1988 Jun; 15(6):1901-8. PubMed ID: 2454615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cisplatin, peplomycin, mitomycin C, and vincristine combination chemotherapy of non-small cell carcinoma of the lung].
    Saito H; Nomura F; Kawatsu H; Sakai S; Kobayashi T; Shimokata K
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2715-8. PubMed ID: 6210062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclophosphamide, doxorubicin, and cisplatin in the treatment of non-small cell bronchogenic carcinoma.
    Evans WK; Feld R; DeBoer G; Osoba D; Curtis JE; Baker MA; Myers RE; Quirt IC; Pritchard KI; Brown TC; Kutas GJ; Blackstein ME; Ottema B; Millband L
    Cancer Treat Rep; 1981; 65(11-12):947-54. PubMed ID: 7028256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small cell lung cancer (SCLC): a randomized trial of cyclophosphamide, adriamycin, vincristine plus etoposide (CAV-E) or teniposide (CAV-T) as induction treatment, followed in complete responders by alpha-interferon or no treatment, as maintenance therapy.
    Tummarello D; Graziano F; Mari D; Cetto G; Pasini F; Antonio S; Isidori P; Gasparini S
    Anticancer Res; 1994; 14(5B):2221-7. PubMed ID: 7840527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Combination chemotherapy consisting of cis-platinum and adriamycin in non-small cell carcinoma of the lung].
    Fujii M; Okabe K; Ishikawa M; Toki H; Fujita Y; Araki Y
    Gan To Kagaku Ryoho; 1984 Feb; 11(2):265-9. PubMed ID: 6198968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A randomized trial with various combinations of cis-platinum (CDDP), mitomycin C (MMC), peplomycin (PEP) and ftorafur (FT) in the treatment of non-small cell lung cancer].
    Nakabayashi T; Yasuda S; Miyamoto H; Abe S; Ohosaki Y
    Gan To Kagaku Ryoho; 1986 Oct; 13(10):2998-3004. PubMed ID: 2429619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scheduled and unscheduled combination chemotherapy in the treatment of squamous cell lung cancer (cyclophosphamide, adriamycin, vincristine and bleomycin, with and without cis-platinum).
    Jones DH; Bleehen NM; Grant RM; Plowman PN; Roberts JT; Sikora K; Watson JV; Wiltshire CR
    Anticancer Res; 1983; 3(4):235-8. PubMed ID: 6192751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [CDDP-containing combination chemotherapy for advanced lung cancer].
    Asamoto H; Hisa T; Sawano T; Sakai K; Kitamura S; Matsushita N; Kokura M; Satake H; Kawakami I
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2544-9. PubMed ID: 6210053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of cisplatin, cyclophosphamide, vincristine, and doxorubicin for the treatment of non-small cell lung cancer.
    Lindgren D; Cadman E; Erichson R; Grann V; Sachs K
    Cancer Treat Rep; 1984 Sep; 68(9):1159-61. PubMed ID: 6090015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized trial of hybrid administration of cyclophosphamide, doxorubicin, and vincristine (CAV)/cisplatin and etoposide (PVP) versus sequential administration of CAV-PVP for the treatment of patients with small cell lung carcinoma: results of long term follow-up.
    Ueoka H; Kiura K; Tabata M; Kamei H; Gemba K; Sakae K; Hiraki Y; Hiraki S; Segawa Y; Harada M
    Cancer; 1998 Jul; 83(2):283-90. PubMed ID: 9669811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
    Gohji K; Higuchi A; Maruyama S; Minayoshi K; Fujii A; Itoh N; Hasunuma Y; Tanaka H; Izumi T
    Jpn J Clin Oncol; 1993 Oct; 23(5):291-8. PubMed ID: 7693990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Combination chemotherapy with etoposide, mitomycin C, and cyclophosphamide in advanced non-small cell lung cancer].
    Homma T; Yoneda S; Fukuda Y; Nakata M; Noguchi Y; Yoshida S
    Gan To Kagaku Ryoho; 1986 Jul; 13(7):2399-403. PubMed ID: 3015045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination chemotherapy in metastatic or recurrent non-small cell bronchogenic carcinoma. 5-year results.
    Ojala A; Nikkanen VN; Paloheimo S; Palojoki A; Thölix E
    Strahlentherapie; 1983 Dec; 159(12):775-7. PubMed ID: 6364459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cisplatin, doxorubicin, cyclophosphamide, lomustine, and vincristine (PACCO) in the treatment of non-small cell bronchogenic carcinoma.
    Whitehead RP; Rosenbaum PR; Carbone PP
    Cancer Treat Rep; 1984 May; 68(5):771-3. PubMed ID: 6539171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination chemotherapy in squamous cell carcinoma of the lung.
    Krzakowski MJ; Swierz J
    Chemioterapia; 1984 Apr; 3(2):75-8. PubMed ID: 6085285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Combination chemotherapy including cisplatin in lung cancer by bronchial artery infusion].
    Miyake M; Hiraki Y; Douke T; Kashitani N; Kondou S; Kimoto S; Hashimoto K; Aono K; Tanaka N; Inoue F
    Rinsho Hoshasen; 1988 Jan; 33(1):35-40. PubMed ID: 2452907
    [No Abstract]   [Full Text] [Related]  

  • 18. Adriamycin and cis-dichlorodiammineplatinum in nonresectable and metastatic carcinoma of the lung.
    Morris RW; Brubaker LH; Kardinal CG; Carolla RL; Perry MC
    Cancer Clin Trials; 1979; 2(1):37-41. PubMed ID: 229982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current status in the treatment of inoperable non-small cell lung cancer (NSCLC)].
    Nishimura M; Sugiura T; Urata A; Ota K
    Gan To Kagaku Ryoho; 1985 Jan; 12(1):54-60. PubMed ID: 2578274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cisplatin, adriamycin and VP-16 (CAV) in the treatment of small cell carcinoma of the lung].
    Yokoyama A; Kinameri K; Kurita Y
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2573-8. PubMed ID: 6095762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.